TAOX
TAO Synergies Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.25
−2.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 68.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.41x
- Price / sales
- 31.48x
- Price / cash flow
- -3.92x
Enterprise value
- Enterprise value
- $9.7M
- EV / sales
- 12.54x
- EV / EBITDA
- -1.16x
- EV / EBIT
- -1.16x
- Market cap
- $24.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026